No Chart Data Available
No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹436.6Prev. Close
₹445.65Turnover(Lac.)
₹1.79Day's High
₹448Day's Low
₹436.652 Week's High
₹850.952 Week's Low
₹415Book Value
₹596.88Face Value
₹10Mkt Cap (₹ Cr.)
159.22P/E
9.01EPS
49.45Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 3.57 | 3.57 | 3.57 | 3.57 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 197.63 | 173.92 | 151.23 | 152.48 |
Net Worth | 201.2 | 177.49 | 154.8 | 156.05 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 96.56 | 70.57 | 92.47 | 95.47 |
yoy growth (%) | 36.82 | -23.67 | -3.13 | 23.96 |
Raw materials | -50.06 | -40.02 | -53.57 | -48.67 |
As % of sales | 51.84 | 56.71 | 57.93 | 50.98 |
Employee costs | -10.18 | -9.7 | -8.56 | -6.75 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 17.59 | 9.11 | 18.04 | 24.88 |
Depreciation | -1.98 | -2 | -1.56 | -1.55 |
Tax paid | -4.05 | -1.98 | -5.6 | -8.26 |
Working capital | 11.57 | 22.79 | -3.33 | 10.21 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 36.82 | -23.67 | -3.13 | 23.96 |
Op profit growth | 199.58 | -65.14 | -34.33 | 41.59 |
EBIT growth | 92.21 | -49.25 | -27.44 | 42.53 |
Net profit growth | 90.09 | -42.7 | -23.62 | 31.45 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,610.2 | 88.96 | 3,86,340.92 | 705.44 | 0.99 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,042.2 | 63.8 | 1,60,401.43 | 696 | 0.5 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,994 | 63.34 | 1,35,175.11 | 597 | 0.15 | 2,707 | 249.82 |
Cipla Ltd CIPLA | 1,325.85 | 23.38 | 1,07,099.6 | 616.88 | 1.21 | 4,256.93 | 411.55 |
Dr Reddys Laboratories Ltd DRREDDY | 1,182.75 | 21.28 | 98,715.91 | 90.6 | 0.68 | 4,266.4 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time Director
Girish Dhameja
Non Executive Director / Chief Financial Officer
Sushma Chinchane
Independent Non Exe. Director
Saurabh Shah
Independent Non Exe. Director
Malay Doshi
Non Executive Director
Rajendrasinh Rana
Independent Non Exe. Director
Pooja Hindia
Company Sec. & Compli. Officer
DHWANI KARNA DESAI
SF-206 Silver Oak Complex,
BPC Road,
Gujarat - 390020
Tel: 91-022-2500 5245/46
Website: http://www.corallab.com
Email: cs@corallab.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Coral Laboratories Limited (CLL) was established in February, 1997. It was promoted by Navin B Doshi of the DWD Group. To manufacture pharmaceutical formulations like tablets, capsules, liquid and top...
Read More
Reports by Coral Laboratories Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.